The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFocusrite Regulatory News (TUNE)

Share Price Information for Focusrite (TUNE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 380.00
Bid: 370.00
Ask: 390.00
Change: 0.00 (0.00%)
Spread: 20.00 (5.405%)
Open: 380.00
High: 380.00
Low: 380.00
Prev. Close: 380.00
TUNE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Management Shares

18 May 2021 07:00

RNS Number : 9103Y
Focusrite PLC
18 May 2021
 

Strictly embargoed until 07:00 on 18 May 2021

Focusrite plc

("the Company" or "the Group")

Issue of Management Shares

Focusrite plc (AIM: TUNE), the global music and audio products company supplying hardware and software used by professional and amateur musicians and the entertainment industry, is pleased to announce the issue of 13,337 management share awards to the Company's recently appointed Chief Financial Officer, Sally McKone.

The shares, to be issued from the Company's Employee Benefit Trust were determined by the Company's Remuneration Committee and approved by the Board.

The shares will vest in three tranches; the first tranche of 3,176 shares vested in March 2021, the second tranche of 4,029 shares will vest in March 2022 and the third tranche of 6,132 shares will vest in March 2023.

Following the announcement of the Company's interim results, on 13 May 2021 the Company has awarded the first tranche on 17 May 2021 which comprises 3,176 shares. After the Company cash settled the resulting tax and deducted the National Insurance element, Sally McKone will be awarded a net holding of shares in the first tranche resulting in total beneficial holding of 1,683 being 0.003% of the issued ordinary share capital of the Company.

The information set out below is provided in accordance with the requirements of Article 19(3) of the Market Abuse Regulation (EU) No 596/2014.

1

Details of the persons discharging managerial responsibilities person closely associated

a)

Name

Sally McKone

2

Reason for the notification

a)

Position/status

 Chief Financial Officer

b)

Initial notification /Amendment

 Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Focusrite plc

b)

LEI

213800JJ51KA4LOTF736

4A

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of 0.1p each in Focusrite plc

Identification code

GB00BSBMW716

b)

Nature of the transaction

Issue of shares ordinary shares from EBT of 0.1p each in Focusrite plc.

c)

Price(s) and volume(s)

 

Price(s)

Volumes

Nil cost

3,176 (settled in part by the transfer of 1,683 ordinary shares and in part with a cash payment equal to market value of 1,493 ordinary shares to meet the PDMR's liability to income tax and employee national insurance arising on the issue of 3,176 shares)

 

d)

Aggregated information

- Aggregated volume 

- Price 

Not applicable - single transaction

e)

Date of the transaction

17 May 2021

f)

Place of the transaction

Outside a trading venue

 

 

-ends-

Enquiries:

Focusrite plc: +44 1494 836301

Tim Carroll (CEO)

Sally McKone (CFO)

 

Panmure Gordon (Nominated Adviser and Broker) +44 20 7886 2500

Freddy Crossley / Alina Vaskina

Erik Anderson

 

Belvedere Communications +44 20 3687 2756

John West

Llew Angus

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

 

 

Notes to Editors

Focusrite plc is a global music and audio products group that develops and markets proprietary hardware and software products. Used by recording professionals and musicians alike, its solutions facilitate the high-quality production of recorded and live sound. The Focusrite Group trades under six established brands: Focusrite, Focusrite Pro, Novation, Ampify, ADAM Audio and Martin Audio.

With a high-quality reputation and a rich heritage spanning decades, its brands are category leaders in the music-making and audio recording industries. Focusrite and Focusrite Pro offer audio interfaces and other products for recording musicians, producers and professional audio facilities. Novation and Ampify products are used in the creation of electronic music, from synthesisers and grooveboxes to industry-shaping controllers and inspirational music-making apps. ADAM Audio studio monitors have earned a worldwide reputation based on technological innovation in the field of studio loudspeaker technology. Martin Audio designs and manufactures performance-ready systems across the spectrum of sound reinforcement applications. Sequential designs and manufacturers high end analogue synthesizers.

The Focusrite Group has offices in four continents and a global customer base with a distribution network covering approximately 160 territories.

Focusrite plc is traded on the AIM market, London Stock Exchange.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHARMRTMTBBBPB
Date   Source Headline
13th Sep 20177:00 amRNSTrading Update
31st Aug 20177:00 amRNSTR-1: Notification of major holdings
19th May 20173:40 pmRNSHolding(s) in Company
3rd May 20177:00 amRNSHalf Year Results for the period ended 28 Feb 2017
20th Mar 20177:00 amRNSTrading Update
24th Feb 20173:56 pmRNSPDMR Grant of Share Options
10th Jan 20172:46 pmRNSResult of AGM
10th Jan 20177:00 amRNSAGM Statement
7th Dec 20164:28 pmRNSTR-1: Notification of Major Interest in Shares
6th Dec 201611:00 amRNSAnalyst and Investor Day
5th Dec 20163:13 pmRNSDirector/PDMR Shareholding
5th Dec 20167:00 amRNSAppointment of Chief Executive Officer
24th Nov 20165:09 pmRNSDirector/PDMR Shareholding
22nd Nov 20166:15 pmRNSDirector/PDMR Shareholding
22nd Nov 20167:00 amRNSFinal Results for the Year Ended 31 August 2016
6th Oct 20167:00 amRNSFurther Expansion into Asia
14th Sep 20167:00 amRNSPre-close Trading Update
19th Jul 20167:00 amRNSBoard Change
2nd Jun 20167:00 amRNSMajor New Product Upgrade and Launch
6th May 20162:56 pmRNSHolding(s) in Company & Total Voting Rights
26th Apr 20167:00 amRNSHalf Year Results
19th Apr 20169:22 amRNSNotice of Interim Results
14th Mar 20167:00 amRNSTrading Update
29th Jan 20163:34 pmRNSResult of AGM
29th Jan 20167:00 amRNSAGM Statement and Update on Trading
9th Dec 20157:00 amRNSResults for the year ended 31 August 2015
23rd Nov 20157:00 amRNSNotice of Preliminary Results
15th Sep 20157:00 amRNSPre-close Trading Update
6th May 20157:01 amRNSDividend Timetable
29th Apr 20157:00 amRNSHalf Year Results for the period ended 28 Feb 2015
18th Mar 20157:00 amRNSQ1 products and news update
12th Mar 20157:00 amRNSTrading Update
12th Dec 20145:37 pmRNSTR-1: Notification of Major Interest in Shares
11th Dec 20147:00 amRNSAdmission to AIM and first day of dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.